Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Alliance
-
-
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
-
Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
-
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
-
Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung
-
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
-
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
-
Paclitaxel in Treating Women With Recurrent Solid Tumors
-
Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin’s Lymphoma
-
Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
Categories
Alliance Committee
Browse by Year